Karen Smith

Altimmune is a clinical stage immunotherapeutics company focused on the development of products to stimulate robust and durable immune responses for the prevention and treatment of diseases. We strategically employ our two distinct and complementary immune platform technologies to create innovative candidates for important diseases.